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Early and midterm outcome of a novel technique to
simplify the hybrid procedures in the treatment of
thoracoabdominal and pararenal aortic aneurysmsThis manuscript details a large center’s experience with
debranching of the visceral aorta and subsequent endovas-
cular stent graft implantation in the treatment of thoraco-
abdominal aortic aneurysms (TAAAs) and pararenal aortic
aneurysms (PAAAs). Their hybrid technique specifically
utilizes a polytetrafluoroethylene self-expanding stent graft
(Viabahn graft; WL Gore & Associates, Flagstaff, Ariz).
The distal anastomosis is created using the Seldinger tech-
nique with several stay sutures to the graft body while the
proximal anastomosis is sutured in the traditional fashion.
They conclude that use of stent graft technology in this
reconstruction is safe and may represent a technical advance
in the hybrid repair of TAAAs and PAAAs.
In 2009, several reconstructions were added to the
CPT manual in order to facilitate the reporting of de-
branching procedures that extend the proximal or distal
landing zones in the visceral aorta for endovascular repair.
However, this manuscript uses self-expanding stent graft
technology manipulated through open surgery. The distal
anastomosis is not created using standard open suturing.
Unfortunately, from a CPT perspective, this difference is
large enough that no coding exists to describe such a
revascularization to each visceral arterial bed. The unlisted
vascular CPT code 37799 is, therefore, the appropriate
description for each bypass performed. This will require
submission of medical records and will be subject to review
by a medical director.
One method for extending the length of distal fixation
in endovascular repair of the thoracic aorta requires ligation
of the celiac, superior mesenteric, and/or renal arteries and
creating a reconstruction that originates from a more distal
inflow source. If an iliac artery is chosen as that inflow using
“other than vein” conduit, the ilio-celiac (CPT code 35632),
ilio-mesenteric (CPT code 35633), and ilio-renal (CPT
code 35634) descriptions could be appropriate. The CPT
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addressed, the second revascularization would require that
the59 modifier be appended to clarify this as separate and
distinct. No specific CPT codes exist in parallel for use of
autogenous conduit. Therefore, the “repair blood vessel”
coding set would be a reasonable alternative for the iliac
artery-based reconstructions using autogenous tissue. CPT
code 35251 describes “repair blood vessel with vein graft;
intra-abdominal”. If all four vessels were treated in this
manner, the latter three would be reported with a 59
modifier following the example above. If the visceral vessels
are moved to the infrarenal aorta as an inflow source,
aorto-renal with vein (CPT code 35560), aorto-renal with
“other than vein” (CPT code 35631), aorto-mesenteric or
aorto-celiacwithvein (CPTcode35531),or aorto-mesentericor
aorto-celiac with “other than vein” (CPT code 35631) may
be appropriate.
The length of the proximal aortic seal can be extended
to allow for endovascular repair of an abdominal aneurysm.
This may require extra-anatomic bypass(es) which include
hepato-renal with vein (CPT code 35535) on the right,
spleno-renal with vein (CPT code 35536) on the left, and a
direct splenic artery to the left renal artery anastomosis after
skeletonization/mobilization of the splenic artery off the
pancreas (CPT code 35636). Other options using the
supraceliac aorta for inflow are listed above.
The staged thoracic or abdominal aortic aneurysm re-
pairs would follow standard component coding guidelines
detailed elsewhere. Since these debranching reconstruc-
tions have associated 90-day global periods, the subsequent
endovascular therapies would require a58 “staged” mod-
ifier for appropriate reimbursement.
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